Chronic Endometritis and IVF: Silent Inflammation, Biopsy & Treatment
Key Takeaways
Chronic endometritis is a lasting, low-grade inflammation of the uterine lining. It is not the same as acute endometritis: symptoms may be mild or absent, yet the lining may still be less ready for implantation. Ultrasound alone cannot make the diagnosis. Confirmation usually needs an endometrial biopsy with plasma-cell (CD138) staining. It is looked for when the history points to it, not as routine screening before a first IVF cycle.
Key evidence: Kimura et al. — Review: Chronic endometritis and its effect on reproduction (2019) ESHRE Good Practice Recommendations on Recurrent Implantation Failure (2023) Wei et al. 2026 — antibiotic cure and subsequent FET outcomes
On this page
- What chronic endometritis is
- Why it matters in IVF
- Why it is easy to miss
- How chronic endometritis is diagnosed
- When it is usually investigated
- Treatment for chronic endometritis
- How successful is antibiotic treatment?
- What treatment does — and does not — promise
- Frequently Asked Questions for Dr. Aksoy
- More questions about chronic endometritis
What chronic endometritis is
Some pelvic infections announce themselves: fever, pain, and a clear sense of urgency.
Chronic endometritis usually does not. It is a low-grade, lasting inflammation of the uterine lining. Immune cells — especially plasma cells — stay in the endometrium. You may feel well, and the lining can still be less receptive for implantation.
That silence is why a routine pelvic ultrasound so often misses it. Ultrasound alone rarely proves the diagnosis. Confirmation usually needs an endometrial biopsy with plasma-cell staining (often CD138). The biopsy is sometimes done after hysteroscopy, when the cavity looks irregular or when implantation has failed more than once.
This is why the condition comes up after recurrent implantation failure, recurrent pregnancy loss, or unexplained infertility. Couples travelling for IVF abroad should bring prior biopsy or hysteroscopy reports when they have them. The receiving team can then decide whether the cavity needs another look before transfer.
Why it matters in IVF
Confirmed chronic endometritis is linked with poorer reproductive outcomes in selected groups, especially after repeated IVF failure (Kimura et al., 2019). It does not explain every failed cycle, and it is not a reason to screen every patient automatically.
Chronic inflammation is reported to change the immune cells in the endometrium and the way the lining prepares for pregnancy (decidualisation). These changes are thought to affect fertility (Kimura et al., 2019).
Not every failed IVF attempt comes from lining inflammation. When the history genuinely raises concern, chronic endometritis is worth investigating, together with embryo chromosomal quality, transfer technique, and structural findings in the cavity.
Why it is easy to miss
Many women have no symptoms at all. When symptoms do appear, they may include:
- light spotting between periods,
- irregular bleeding,
- a vague, mild pelvic ache,
- unusual vaginal discharge.
None of these signs is specific enough to confirm or exclude the diagnosis, and ordinary cycle variation can look the same.
Acute endometritis is a different picture. Fever or marked pelvic pain, particularly after childbirth, miscarriage, or an intrauterine procedure, calls for prompt medical assessment (StatPearls, 2024).
How chronic endometritis is diagnosed
Diagnosis usually relies on an endometrial biopsy assessed for stromal plasma cells, often with CD138 immunostaining and sometimes alongside hysteroscopy.
Common tools:
| Tool | Clinical role |
|---|---|
| Hysteroscopy | May show micropolyps, focal redness, or stromal swelling — clues, not proof |
| Endometrial biopsy | Obtains tissue from the cavity for histology |
| CD138 staining | Helps identify plasma cells; results must be interpreted with the histology and clinical context |
| Microbial culture | May identify specific organisms; practice varies by centre |
The lining may look normal in thickness and texture on ultrasound even when plasma cells are found in tissue. Biopsy is therefore the main diagnostic method, but there is no universally agreed plasma-cell threshold. A 2026 international expert consensus proposed a provisional cut-off of at least 5 endometrial stromal plasma cells per 10 high-power fields (about 0.5 per field). That is not the same as 5 cells in a single field. The panel still asked for clinical context and external validation (Kitaya et al., 2026). CD138 findings need to be read with routine histology, biopsy timing, and the clinical history.
When it is usually investigated
Investigation may be considered when the history raises a specific concern.
Contexts in which clinicians may discuss an assessment include:
- recurrent implantation failure after good-quality transfers (ESHRE, 2023),
- recurrent early pregnancy loss (ASRM, 2026),
- otherwise unexplained infertility after a thorough standard workup, when other findings also raise suspicion,
- micropolyps or focal red areas seen at diagnostic hysteroscopy.
Routine endometrial biopsy before a first IVF cycle is not supported by high-level evidence. The value of testing depends on what has already happened. See our guide on hysteroscopy in female infertility.
Treatment for chronic endometritis
When chronic endometritis is confirmed, oral antibiotics may be offered according to the clinical context, local protocol, and microbiology where available. ESHRE’s 2023 recommendations say that assessment for chronic endometritis, and antibiotic treatment if it is diagnosed, “can be considered” in recurrent implantation failure (ESHRE, 2023). Whether to repeat the biopsy before transfer is an individual decision.
The choice of antibiotic and treatment length vary between centres. Culture results, previous treatment, allergies, and local resistance patterns may influence the plan.
Some teams recommend a test of cure — a second endometrial biopsy after treatment — particularly after recurrent implantation failure or when only a limited number of euploid (chromosomally normal) embryos remain. ASRM notes that such a biopsy can be done after the next menstrual cycle following antibiotics (ASRM, 2026).
Empirical antibiotics should not become routine after a failed transfer. Treatment should follow an individualised assessment when endometrial tissue findings support the diagnosis; otherwise patients may face side effects without proven benefit.
How successful is antibiotic treatment?
In one large single-hospital retrospective series (a study that looks back at records rather than assigning treatment at random), women with chronic endometritis after a first failed transfer took one course of oral antibiotics. On repeat biopsy, the inflammation had cleared in about 81%. Women whose inflammation cleared had higher pregnancy and live-birth rates in the next frozen transfer than women whose inflammation persisted (Wei et al., 2026). That is a group result, not a personal forecast.
Evidence beyond this cohort is mixed. ESHRE’s 2023 recommendations note that published reviews disagree on whether antibiotic treatment improves pregnancy or live-birth rates (ESHRE, 2023). In recurrent pregnancy loss, ASRM’s 2026 committee opinion lists treatment of chronic endometritis among treatments of possible benefit, based on limited or conflicting studies. It also describes a randomised trial (one that assigns women by chance to treatment or placebo), presented as an abstract. In it, 438 women with recurrent pregnancy loss and biopsy-confirmed chronic endometritis took doxycycline for two weeks or placebo. Miscarriage and live-birth rates did not differ significantly (ASRM, 2026).
Evidence box: Wei et al. 2026 study numbers
A cohort (a defined group followed for outcomes) of 2,555 frozen-embryo-transfer cycles gave the following figures. Among women diagnosed after implantation failure, one course of oral antibiotics cleared the inflammation in 80.7% of cases (309 of 383), confirmed on a repeat CD138 biopsy (Wei et al., 2026).
Women with documented histological clearance had higher clinical-pregnancy and live-birth rates in the next frozen transfer than those with persistent inflammation. This was an association in a retrospective, single-centre cohort of women treated after a first implantation failure; it does not prove that antibiotics caused the difference. A repeat biopsy can be clinically informative in selected cases because it documents whether plasma-cell inflammation is still present.
Dr. Aksoy’s Approach
Dr. Aksoy treats the roughly 81% histological-clearance figure as encouraging, not as proof that every patient is cured or will become pregnant. After recurrent implantation failure, or when few euploid embryos remain, he may recommend a control biopsy rather than assume that treatment worked. If inflammation persists, he reassesses the original diagnosis and looks for polyps, adhesions, or another focus in the cavity before considering further antibiotics. The decision is individualised; a control biopsy is not a routine formality for everyone.
What treatment does — and does not — promise
Treating confirmed inflammation may improve the endometrial environment in selected patients, but it does not guarantee implantation or pregnancy. Resolution removes one contributing factor. Pregnancy still depends on several others:
- a chromosomally normal embryo (euploidy),
- the woman’s age,
- appropriate hormone preparation and transfer timing,
- sperm quality and fertilisation,
- a structurally sound uterine cavity.
If transfers still fail after documented endometrial cure, the next step is a wider review — not another round of the same antibiotics. See our guide on what to review after IVF failure.
Request a Case Review
If a transfer has not worked, you may want to know whether chronic endometritis, a cavity finding, or timing played a part. Reviewing previous biopsy and hysteroscopy reports with a fertility specialist is a reasonable next step. You can contact the clinic to discuss which records are relevant before sending medical information.
Related reading
- ERA Test in IVF: When It Helps and Why It Is Controversial
- Hysteroscopy in Female Infertility: Indications and Evidence
- Unexplained Infertility: What the Diagnosis Means
Frequently Asked Questions for Dr. Aksoy
Does chronic endometritis always prevent pregnancy? What is your approach to transfer after treatment and histological cure?
No, chronic endometritis does not always prevent pregnancy. We are talking about a lasting inflammatory condition of the uterine lining that often causes no symptoms. Some women conceive spontaneously even while they have chronic endometritis. That said, studies suggest it may be linked, especially with recurrent implantation failure and pregnancy loss. We cannot say that this link is a direct cause-and-effect relationship in every patient.
When chronic endometritis is reliably confirmed, I consider antibiotic treatment. Especially in patients who have already had repeated transfer failures, it matters to me to see on a control biopsy after treatment that the inflammation has cleared. If histological cure is confirmed and there is no other problem, I do not delay transfer for months without reason. I also do not think every patient must have a control biopsy. That is because, although better pregnancy outcomes have been associated with clearance after treatment, it has not yet been firmly proven that antibiotics alone raise the live-birth rate.
Does a positive CD138 result always mean antibiotics and delaying embryo transfer?
No. When CD138 is positive, it is not right to start antibiotics automatically and delay embryo transfer. CD138 is a marker that helps us show plasma cells in the endometrium. What matters is not only whether the result is positive, but how many plasma cells are found, how they are counted, and the patient’s clinical history.
Today there is no single CD138 threshold accepted worldwide for diagnosing chronic endometritis. Some laboratories call even one plasma cell positive; others use higher thresholds. If only a very small number of plasma cells are found and the patient has no prior transfer failure or recurrent pregnancy loss, I do not take that result alone as a reason to treat. By contrast, when there is a clear increase in plasma cells, matching histological findings, and repeated failures, antibiotic treatment and confirming clearance before transfer become more meaningful.
What matters to me is treating the patient, not a laboratory result. Unnecessary antibiotics and unnecessary delay of transfer can both harm the patient.
Can chronic endometritis that cleared with antibiotics come back? Do you need to look again before transfer or in pregnancy?
Yes, chronic endometritis can reappear after it has cleared with antibiotics. Sometimes what we take for recurrence is actually endometritis that had not fully cleared after the first treatment. That does not mean every woman who has had chronic endometritis needs regular biopsies.
If histological cure was confirmed after treatment, there are no new symptoms, and there are no extra risks such as earlier transfer failures, I do not keep repeating CD138 testing before every transfer. If new abnormal bleeding, chronic pelvic pain, repeated implantation failure or pregnancy loss appears, reassessment can be considered. Once a pregnancy is established, we do not routinely biopsy the endometrium because of a past chronic endometritis history. Infection symptoms that appear in pregnancy are assessed separately.
I tell my patients this in particular: chronic endometritis is a treatable condition. Having had this diagnosis once does not mean your uterus will stay inflamed forever, or that you cannot have a healthy pregnancy in the future.
More questions about chronic endometritis
Can chronic endometritis be diagnosed on ultrasound alone?
No. Ultrasound cannot show microscopic plasma-cell infiltration. Diagnosis relies on an endometrial biopsy and histological examination, often supported by CD138 staining and interpreted in the clinical context.
How does chronic endometritis differ from acute endometritis?
Acute endometritis may present suddenly with fever, marked pelvic pain, and abnormal or pus-like discharge, and it requires prompt medical assessment. Chronic endometritis is usually low-grade and may cause few or no symptoms; it is identified through tissue examination.
Sources
- Kimura F, Takebayashi A, Ishida M, et al. Review: Chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019;45(5):951-960.
- ESHRE Working Group on Recurrent Implantation Failure. Good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023.
- American Society for Reproductive Medicine. Recurrent pregnancy loss: a committee opinion. 2026.
- StatPearls. Endometritis. StatPearls Publishing; 2024.
- Wei L, Zhang Y, Wang S, Xu S, Hu W. Association of cured chronic endometritis after antibiotic treatment with outcomes of the subsequent frozen-thawed embryo transfer cycle among women with first implantation failure: a retrospective cohort study. BMC Pregnancy Childbirth. 2026;26(1):733.
- Kitaya K, Kuroda K, Jwa SC, et al. International expert consensus statement on chronic endometritis: a comprehensive literature review and modified e-Delphi study. Reprod Med Biol. 2026;25(1):e70066.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.